Docetaxel 160 Mg Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL
Reference Brands: Taxotere (US & EU)
Category:
Oncology Cancer Care
Docetaxel Injection is an oncology drug used to treat breast, lung, prostate, and gastric cancers. Offered in 20 mg, 80 mg, and 160 mg strengths, our EU-GMP and USFDA-compliant formulations are available for B2B supply, licensing, and private labeling. Suitable for distributors and hospital tenders, with alcohol-free options and full regulatory support.
Docetaxel 160 mg Injection is available in Injection
and strengths such as 20 mg/0.5 mL, 80 mg/2 mL, 160 mg/4 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Docetaxel 160 mg Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Docetaxel 160 mg Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Docetaxel Injection is a widely used cytotoxic chemotherapy drug indicated for breast, lung, prostate, gastric, and head & neck cancers. We offer Docetaxel in EU-GMP and USFDA-compliant injectable formulations, including 20 mg, 80 mg, and 160 mg single-use vials. Available for B2B supply, contract manufacturing, and licensing, our Docetaxel meets global regulatory standards with full CTD dossiers and stability data. Alcohol-free and solvent-based options are available. Ideal for distributors, hospitals, and procurement agencies seeking high-quality oncology products. Partner with us for reliable Docetaxel bulk supply or private label opportunities across Europe, the US, and emerging regulated markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing